BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 47 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $206,000 | -8.4% | 5,309 | +0.1% | 0.00% | – |
| Q2 2022 | $225,000 | -6.6% | 5,303 | +0.1% | 0.00% | – |
| Q1 2022 | $241,000 | -34.0% | 5,297 | -29.5% | 0.00% | -100.0% |
| Q4 2021 | $365,000 | -14.3% | 7,515 | -15.9% | 0.00% | 0.0% |
| Q3 2021 | $426,000 | -6.6% | 8,936 | -5.0% | 0.00% | 0.0% |
| Q2 2021 | $456,000 | -51.8% | 9,404 | -54.1% | 0.00% | -50.0% |
| Q1 2021 | $947,000 | -2.1% | 20,474 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $967,000 | +6.5% | 20,322 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $908,000 | +5.5% | 21,180 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $861,000 | +13.9% | 21,110 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $756,000 | -12.5% | 20,967 | +3.1% | 0.00% | 0.0% |
| Q4 2019 | $864,000 | – | 20,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
| Diversified, LLC | 19,077 | $818,000 | 0.70% |
| CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
| Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
| Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
| Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
| Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
| Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |